Intellia Therapeutics: Funding, Investors & Team (Oct 2026)
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.
Intellia Therapeutics has raised $180M across 1 funding round on record, the most recent an undisclosed round of $180M announced in Apr 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Intellia Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Intellia Therapeutics Funding Rounds
Intellia Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Intellia Therapeutics Funding Compared to Other Biotechnology Startups
Intellia Therapeutics' latest round of $180M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Intellia Therapeutics in Biotechnology and Cambridge
Companies Similar to Intellia Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Intellia Therapeutics Funding FAQs
What does Intellia Therapeutics do?
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.
How much funding has Intellia Therapeutics raised?
Intellia Therapeutics has raised $180M across 1 round on record. The most recent is an undisclosed round of $180M announced in Apr 2026.
When did Intellia Therapeutics last raise funding?
Intellia Therapeutics' most recent funding round on record is an undisclosed round of $180M, announced in Apr 2026.
Who founded Intellia Therapeutics?
FundedIQ lists John Leonard (Founder) at Intellia Therapeutics.
Where is Intellia Therapeutics headquartered?
Intellia Therapeutics is based in Cambridge, Massachusetts, United States.
How many employees does Intellia Therapeutics have?
Intellia Therapeutics is in the 251-500 employee band.
How does Intellia Therapeutics' funding compare to other Biotechnology startups?
Intellia Therapeutics' latest round of $180M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Intellia Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Intellia Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.